Daniel Kalbacher
University of Hamburg
71 Papers
46 Citations
Daniel Kalbacher is an academic researcher from University of Hamburg. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 28 publications.
Chat about Author
Papers
Management of patients with mitral regurgitation ineligible for standard therapy undergoing TMVI screening.
Sebastian Ludwig,Roya Sedighian,Jessica Weimann,Benedikt Koell,Lara Waldschmidt,A. Schäfer,Moritz Seiffert,Dirk Westermann,Hermann Reichenspurner,Stefan Blankenberg,Niklas Schofer,Edith Lubos,Lenard Conradi,Daniel Kalbacher +13 more
TL;DR: In MR patients considered ineligible for standard therapy, TMVI provided acceptable clinical outcomes and MR elimination in the majority of patients and in screen-failed patients, bailout-TEER represented a reasonable alternative while MT was associated with poor outcomes.
Applying the TRILUMINATE Eligibility Criteria to Real-World Patients Receiving Tricuspid Valve Transcatheter Edge-to-Edge Repair.
Lukas Stolz,Philipp M. Doldi,Karl-Patrik Kresoja,Sara Bombace,Benedikt Koell,Mohammad Kassar,Johannes Kirchner,L. Weckbach,S. Ludwig,Thomas J. Stocker,Hannah Glaser,A. Schöber,Steffen Massberg,Michael Näbauer,Volker Rudolph,Daniel Kalbacher,Fabien Praz,Philipp Lurz,J. Hausleiter +18 more
TL;DR: Differences in survival and HFH outcomes suggest a limited generalizability of TRILUMINATE to real-world conditions and they indicate the need for additional studies evaluating the outcomes after T-TEER in less selected patient populations.
Echocardiographic Outcomes With Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients.
Leo Marcoff,Konstantinos Koulogiannis,Lilian Aldaia,Anuj Mediratta,Scott M. Chadderdon,Moody Makar,Tobias Ruf,Theresa Ann Maria Gößler,Jonathan G. Zaroff,Gordon K. Leung,Ivy A. Ku,Michael Nabauer,Paul A. Grayburn,Zuyue Wang,Katie Hawthorne,Dale Fowler,Jacob P. Dal-Bianco,Mani A. Vannan,Carmine Bevilacqua,Massimiliano Meineri,Joerg Ender,Anna Flo Forner,Jyothy Puthumana,Atizazul Hassan Mansoor,Dustin J Lloyd,Steven J. Voskanian,Andrew Ghobrial,Rebecca T. Hahn,Feroze Mahmood,Christiane Haeffele,Geraldine Ong,Leonhard-Moritz Schneider,Dee Wang,Nishant K. Sekaran,Elana Koss,Priti Mehla,Serge Harb,Rhonda Miyasaka,M. N. Ivannikova,Terri Stewart-Dehner,Lucas Mitchel,Sasan R. Raissi,Daniel Kalbacher,Santanu Biswas,Edwin C. Ho,Ythan Goldberg,Robert L. Smith,J. Hausleiter,D. S. Lim,Linda D. Gillam +49 more
TL;DR: Results demonstrate that MR ≤1+ is an achievable benchmark for successful M-TEER and treatment with PASCAL and a smaller flail gap were significant factors in sustaining MR ≤1+ to 6 months.
Tricuspid Regurgitation Disease Stages and Treatment Outcomes After Transcatheter Tricuspid Valve Repair.
Florian Schlotter,Lukas Stolz,Karl-Patrik Kresoja,J. von Stein,V. Fortmeier,Benedikt Koell,W. Rottbauer,Mohammad Kassar,A. Schöber,Bjoern Goebel,P. Denti,P. Achouh,Tienush Rassaf,Andreas Rück,Monika Zdanytė,M. Adamo,Flavien Vincent,Philipp Schlegel,R. V. von Bardeleben,Mirjam G. Wild,Stefan Toggweiler,M. Konstandin,E. Van Belle,M. Metra,Tobias Geisler,Rodrigo Estévez-Loureiro,P. Luedike,N. Karam,Francesco Maisano,Philipp Lauten,Fabien Praz,Mirjam Keßler,Megan Heitkemper,Kelli Peterman,Raffi Bekeredjian,Thomas Schmitz,Georg Nickenig,E. Donal,Tobias Kister,Holger Thiele,Karl-Philipp Rommel,Daniel Kalbacher,Volker Rudolph,C. Iliadis,Alexander Lauten,J. Hausleiter,Philipp Lurz,P. Doldi,Jürgen Schreieck,Ludwig T. Weckbach,Andreas Goldschmied,Sebastian Rosch,Edoardo Pancaldi,Roman Pfister,Daniela Tomasoni,S. Baldus,Natacha Rousse,Muhammed Gerçek,Samy Aghezzaf,F. Rudolph,Norbert Frey,Sebastian Ludwig,Philip Raake,C. Pauschinger,Leonhard-Moritz Schneider,Dominik Felbel,Carsten Salomon,Harald Lapp,Tania Puscas,Alain Berrebi,A. Mahabadi,Florian Schindhelm,Berenice Caneiro-Queija,J. C. Echarte +73 more